Please login to the form below

Not currently logged in
Email:
Password:

Economist Conferences 12th Annual Pharmaceuticals Conference

Building a strategy for pharma's new role
What are the strategic options for pharmaceutical players in this era of sky-high expectations and ever tighter controls? What should be driving your agenda - the urge to do more, or the need to do different?

Presented by Economist Conferences, the 12th Annual European Pharmaceuticals Conference, Building a strategy for pharmaís new role is taking place in London, at Le Meridien Piccadilly, on Tuesday February 21st. Chaired by Richard Barker, director-general of the ABPI, the event will provide an opportunity for the pharma industry to debate its strategic options in this era of sky-high expectations and tightening regulatory controls.

Focused and frank presentations from leading industry figures, including representatives from NICE, Abbott, GlaxoSmithKline, Novartis, Pfizer and Ranbaxy, are scheduled alongside discussion and networking time for delegates in discreet surroundings.

Join Pharmaceutical Marketing Europe magazine at the conference on February 21st.  To hear direct views on the strategic shift from ëwhat pharma fearsí to ëwhat pharmaís forí. For more information on the event, please visit: www.economistconferences.com, or call Rita Beidas on +44 (0) 207 576 8118 and reference ìPMî.

30th September 2008

Share

Building a strategy for pharma's new role
What are the strategic options for pharmaceutical players in this era of sky-high expectations and ever tighter controls? What should be driving your agenda - the urge to do more, or the need to do different?

] [Economist Conferences 12th Annual Pharmaceuticals Conference, Building a strategy for pharma's new roleWhat are the strategic options for pharmaceutical players in this era of sky-high expectations and ever tighter controls? What should be driving your agenda - the urge to do more, or the need to do different? , News Article, , ,] -->

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

Products come and go, but a pharma company’s most valuable, durable asset is its reputation, writes Duncan Mackenzie-Reid and Simon Grist
...
Erik
A quest for innovative solutions
UCB looks to the future through a PRISM...
Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...

Infographics